A closer look as some of the latest spirometers and pulmonary function testing (PFT) diagnostic devices on the market from coVita, FutureMed, MGC Diagnostics, and Vitalograph.
MGC Diagnostics Corp
800-950-5597
www.mgcdiagnostics.com
Designed to provide comfort and performance, Platinum Elite Series body plethysmographs from MGC Diagnostics are state-of-the-art devices that seamlessly combine superior testing capabilities with unmatched space efficiency. Technologists appreciate its compact design, user-friendliness, and comprehensive diagnostics, while patients enjoy the spacious interior and generous foot room. (see image above)
Vitalograph Inc
800-255-6626
www.vitalograph.com
The Vitalograph Compact is a respiratory diagnostic workstation with an integrated V-Core flowhead and Spirotrac 6 testing software, allowing you to focus on helping your patients achieve their best spirometry results. The Compact has a touchscreen interface, multiple inputs for peripheral devices, and facilitates respiratory muscle strength in one efficient solution. (top left image)
Vitalograph’s In2itive is a powerful V-Core spirometer that fits in the palm of your hand for accurate and connected testing, wherever it is needed. It has an easy-to-navigate interface and can store more than 10,000 tests. Its robust, detachable flowhead and large touch screen facilitate point-of-care spirometry that is compliant with ATS/ERS 2019 Technical Standards. (right image)
Available from Vitalograph, the tremoflo C-100 is a powerful, portable oscillometry testing solution. The device uses airwave oscillometry, which provides specific information about small airway function. Testing with the tremoflo C-100 requires no forced maneuver, making it ideal for pediatric patients or anyone who might have difficulty performing an FVC blow. (lower left image)
coVita
800-707-5751
www.covita.net
coVita|Bedfont Scientific, leaders in breath analysis equipment, offer the FDA-cleared NObreath FeNO (fractional exhaled nitric oxide) monitor. The NObreath is a noninvasive, quick, and easy-to-perform breath test that is reimbursable, assists in asthma management, aids in prescribing medication, makes safer/monitored adjustments to medication, shows patient adherence to treatment, and aids in differentiating between allergic (eosinophilic) and nonallergic asthma.
Futuremed
800-222-6780
www.futuremed.com
Futuremed’s Discovery-2 is a diagnostic spirometer equipped with features that minimize risks of testing in an office or bedside. Testing is done with single-use antiviral and antibacterial filters, to reduce chance of cross-contamination within the device or in the examination space. All parts of Discovery-2, including the sensor, are easily disinfected, for optimal hygiene.
